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Introduction
Germline mutations in SLC29A3 result in a range of clini-
cally related, recessive syndromes: H syndrome, pigmented
hypertrichosis with insulin-dependent diabetes mellitus
(PHID) syndrome, Faisalabad histiocytosis (FHC), and
sinus histiocytosis with massive lymphadenopathy
(SHML). Main symptoms of these diseases are hyperpig-
mentation with hypertrichosis, sensorineural deafness,
diabetes, short stature, uveitis and “Rosai-Dorfman-like”
histiocytosis.
Case report
We report the case of an eleven-month-old boy with
early-onset recurrent episodes of unprovoked fever lasting
7 to 10 days associated with pericardial effusion, abdom-
inal pain, diarrhea, and inflammation. Physical examina-
tion revealed hyperpigmentation with hypertrichosis,
dysmorphic features and a spleen and liver enlargement.
Failure to thrive, sensorineural deafness, psychomotor
development delay, and a “Rosai-Dorfman like” cheek
lesion further developed. Febrile attacks were not respon-
sive to interleukin-1 and Tumor-Necrosis-Factor blocking
agents. All known causes of genetic autoinflammatory
syndromes were excluded by sequencing (MEFV, NALP3,
mevalonate kinase, NALP12, TNFRSF1). Sequencing of
SLC29A3 gene revealed homozygous missense mutation
c.1088G>A (p.Arg363Gln).
Discussion
This case is the first description of a patient with an auto-
inflammatory disorder due to a mutation in SLC29A3
gene. Genetic defect of SLC29A3 should be considered in
patients with recurrent febrile attacks associated with any
symptoms reminiscent of SLC29A3 broad spectrum of
manifestations, especially hyperpigmentation with
hypertrichosis.
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